Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Endothelial targeting of liposomes encapsulating SOD/catalase mimetic EUK-134 alleviates acute pulmonary inflammation.

Authors: Howard, Melissa D; Greineder, Colin F; Hood, Elizabeth D; Muzykantov, Vladimir R

Published In J Control Release, (2014 Mar 10)

Abstract: Production of excessive levels of reactive oxygen species (ROS) in the vascular endothelium is a common pathogenic pathway in many dangerous conditions, including acute lung injury, ischemia-reperfusion, and inflammation. Ineffective delivery of antioxidants to the endothelium limits their utility for management of these conditions. In this study, we devised a novel translational antioxidant intervention targeted to the vascular endothelium using PEG-liposomes loaded with EUK-134 (EUK), a potent superoxide dismutase/catalase mimetic. EUK loaded into antibody-coated liposomes (size 197.8±4.5 nm diameter, PDI 0.179±0.066) exerted partial activity in the intact carrier, while full activity was recovered upon liposome disruption. For targeting we used antibodies (Abs) to platelet-endothelial cell adhesion molecule (PECAM-1). Both streptavidin-biotin and SATA/SMCC conjugation chemistries provided binding of 125-150 Ab molecules per liposome. Ab/EUK/liposomes, but not IgG/EUK/liposomes: i) bound to endothelial cells and inhibited cytokine-induced inflammatory activation in vitro; and, ii) accumulated in lungs after intravascular injection, providing >60% protection against pulmonary edema in endotoxin-challenged mice (vs <6% protection afforded by IgG/liposome/EUK counterpart). Since the design elements of this drug delivery system are already in clinical use (PEG-liposomes, antibodies, SATA/SMCC conjugation), it is an attractive candidate for translational interventions using antioxidant molecules such as EUK and other clinically acceptable drugs.

PubMed ID: 24412573 Exiting the NIEHS site

MeSH Terms: Animals; Antioxidants/administration & dosage*; Antioxidants/chemistry; Catalase; Cells, Cultured; Human Umbilical Vein Endothelial Cells; Humans; Immunoglobulin G/administration & dosage*; Immunoglobulin G/chemistry; Lipopolysaccharides; Liposomes; Male; Mice; Mice, Inbred C57BL; Organometallic Compounds/administration & dosage*; Organometallic Compounds/chemistry; Platelet Endothelial Cell Adhesion Molecule-1/immunology*; Pneumonia/chemically induced; Pneumonia/drug therapy*; Pneumonia/immunology; Salicylates/administration & dosage*; Salicylates/chemistry; Serum Albumin, Bovine/administration & dosage; Serum Albumin, Bovine/chemistry; Superoxide Dismutase; Vascular Cell Adhesion Molecule-1/immunology

to Top